Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 45 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung CancerCompletedNCT03746262
- Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029）CompletedNCT03743129Phase 2
- Sleep Apnea and Lung CancerStatus unknownNCT03741647
- Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive TherapyCompletedNCT03740126Not applicable
- Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLCCompletedNCT03736837Phase 2
- An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid TumorsCompletedNCT03735628Phase 1
- Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）Status unknownNCT03735264Phase 2
- ICIs Neoadjuvant Therapy in Resectable Non-Small-Cell Lung CancerCompletedNCT03732664Phase 1
- Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain MetastasesStatus unknownNCT03732482Phase 2/3
- A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLCStatus unknownNCT03732001Phase 2
- Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing TreatmentActive, not recruitingNCT03731585Not applicable
- A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung CancerCompletedNCT03728556Phase 3
- Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung CancerStatus unknownNCT03727867Phase 3
- Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung CancerCompletedNCT03727724Phase 2
- Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving LorlatinibCompletedNCT03727477
- Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLCStatus unknownNCT03726736Phase 1/2
- A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer PatientsCompletedNCT03725475
- NSE/Alb as a Prognostic Biomarker for Lung CancerStatus unknownNCT03724604
- Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung CancerActive, not recruitingNCT03724500
- Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer PatientsCompletedNCT03721289
- NEUWAVE Flexible Probe Study #2WithdrawnNCT03713099Not applicable
- Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLCCompletedNCT03712969Phase 4
- Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLCTerminatedNCT03711422Phase 1
- A Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Dirver GenesStatus unknownNCT03710629
- Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerActive, not recruitingNCT03707938Phase 1
- Palliative Thoracic ImmunoRTActive, not recruitingNCT03705806
- Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary ResectionCompletedNCT03704870Phase 2
- Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC)CompletedNCT03700437Not applicable
- Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLCStatus unknownNCT03700333Phase 3
- Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung CancerWithdrawnNCT03699033Phase 2
- Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC AdenocarcinomaTerminatedNCT03696212Phase 1/2
- Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）CompletedNCT03693547Phase 2
- Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip PlatformStatus unknownNCT03692442
- Move For Surgery - A Novel Preconditioning ProgramCompletedNCT03689634Phase 3
- Is Bone Scintigraphy Necessary in cT1N0M0 GGO Non-Small Cell Lung Cancer? (ECTOP-1006)CompletedNCT03689439
- Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung CancerStatus unknownNCT03679936
- Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing SurgeryCompletedNCT03678350Phase 1
- Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung CancerCompletedNCT03673657Phase 2
- Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPiesTerminatedNCT03673332Phase 4
- Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC PatientsStatus unknownNCT03672136Phase 2
- Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and CisplatinStatus unknownNCT03671538Not applicable
- Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)CompletedNCT03669523Phase 2
- Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLCActive, not recruitingNCT03667820Phase 2
- Itraconazole in Non Small Cell Lung CancerStatus unknownNCT03664115Phase 2
- Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung CancerCompletedNCT03659578Phase 2
- Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New BiomarkersCompletedNCT03658460
- CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung CarcinomaCompletedNCT03656705Phase 1
- Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseTerminatedNCT03656627Phase 1
- Dose Individualization of Pemetrexed - IMPROVE-ICompletedNCT03656549Phase 4
- Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 InhibitorsStatus unknownNCT03656094Phase 2
- Dose Individualization of Pemetrexed - IMPROVE-IIICompletedNCT03655834Phase 4
- Dose Individualization of Pemetrexed - IMPROVE-IITerminatedNCT03655821Phase 4
- Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLCStatus unknownNCT03654027Phase 2
- First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) MetastasesCompletedNCT03653546Phase 2/3
- Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung CancerCompletedNCT03652857Phase 2
- Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase InhibitorsStatus unknownNCT03647956Phase 2
- Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid TumorsActive, not recruitingNCT03647163Phase 1/2
- Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid TumorsTerminatedNCT03645928Phase 2
- A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)CompletedNCT03645330
- Combinatory ImmunoTherapy-1 (Com-IT-1) Irradiation and PD-1 Blockade in Locally Advanced / Advanced NSCLCTerminatedNCT03644823Phase 2
- IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation TherapyCompletedNCT03643484
- Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung CancerActive, not recruitingNCT03637816Phase 2/3
- A Study of Apatinib Plus EGFR-TKI as First Line Treatment in Patients With Non-squamous NSCLC Harboring EGFR MutationsStatus unknownNCT03634059Not applicable
- Immunonutrition to Reduce Toxicities in Non-Small Cell Lung CancerWithdrawnNCT03628144Phase 2
- Daily vs. Non-Daily SBRT for NSCLCTerminatedNCT03624907Not applicable
- Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung CancerStatus unknownNCT03624309Phase 2
- E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL CCompletedNCT03623750Phase 1/2
- 1st Line Durvalumab in PS 2 NSCLC PatientsActive, not recruitingNCT03620669Phase 2
- Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLCStatus unknownNCT03616691Phase 2
- A Prospective Study of Electronic Symptom Reporting Via Mobile Phone Among Patients With Advanced Non-Small Cell Lung CancerCompletedNCT03616522
- Noninvasive vs. Invasive Lung EvaluationCompletedNCT03615443
- Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC PatientsCompletedNCT03613467
- Study of Lorlatinib in ROS1 Rearranged NSCLCStatus unknownNCT03612154Phase 2
- Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLCActive, not recruitingNCT03611738Phase 1
- Study of Alkotinib in Patients With Advanced Non Small Cell Lung CancerCompletedNCT03607188Phase 1
- Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation StrategiesCompletedNCT03607149Phase 4
- A Real World Study Based on NGS (TRUMPRWS)Status unknownNCT03605602
- Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLCStatus unknownNCT03603262Phase 1
- Phase I Study of the Combination of Anlotinib With GefitinibStatus unknownNCT03602027Not applicable
- High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung CancerStatus unknownNCT03598517Not applicable
- Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung CancerCompletedNCT03595644Phase 2
- A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsCompletedNCT03595059Phase 1
- Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory StudyStatus unknownNCT03594682Not applicable
- Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesCompletedNCT03590054Phase 1
- Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell LungCompletedNCT03589547Phase 2
- NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyActive, not recruitingNCT03589339Phase 1
- Osimertinib In EGFR Mutant Lung CancerActive, not recruitingNCT03586453Phase 2
- Adaptive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (LARTIA Trial)Status unknownNCT03583723Not applicable
- Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT03580694Phase 1
- Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian StudyCompletedNCT03576937
- QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung CancerWithdrawnNCT03574649Phase 2
- Phase II Umbrella Study Directed by Next Generation SequencingStatus unknownNCT03574402Phase 2
- Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung CancerWithdrawnNCT03574220Early Phase 1
- CTA Expression/Methylation and Response to Pembrolizumab of NSCLC PatientsStatus unknownNCT03571360Phase 2
- High Intensity Functional Image Guided Vmat Lung EvasionCompletedNCT03569072Not applicable
- Phase I Study of the Combination of Anlotinib With Pemetrexed or DocetaxelStatus unknownNCT03566576Not applicable
- Aggressive Thoracic Radiotherapy for Stage Ⅳ Non Small Cell Lung CancerStatus unknownNCT03565120Not applicable
- 18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLCCompletedNCT03564197Not applicable
- Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial ObstructionTerminatedNCT03564054Not applicable
- Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.Status unknownNCT03563482Not applicable